NCT03610451

Brief Summary

The study proposed in this protocol aims to document the effect of Floatation-REST (reduced environmental stimulation therapy) on symptoms of anorexia nervosa.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2018

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 19, 2018

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 1, 2018

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

October 5, 2023

Status Verified

October 1, 2023

Enrollment Period

4 years

First QC Date

March 19, 2018

Last Update Submit

October 4, 2023

Conditions

Keywords

Anorexia nervosaFloatation therapy

Outcome Measures

Primary Outcomes (1)

  • Body image dissatisfaction score on the Photographic Figure Rating Scale

    Average of the absolute change in body image dissatisfaction from pre to post float across all eight floats (score range: 0 to 10; larger changes indicate greater severity of body image dissatisfaction)

    Through study completion, an average of 1 year

Secondary Outcomes (8)

  • Anxiety on the Spielberger State Trait Anxiety Inventory

    Through study completion, an average of 1 year

  • Anxiety on the NIH Promis Anxiety Scale

    Through study completion, an average of 1 year

  • Anxiety sensitivity on the Anxiety Sensitivity Index-3R

    Through study completion, an average of 1 year

  • Eating disorder severity on the Eating Disorder Examination Questionnaire

    Through study completion, an average of 1 year

  • Functional ability on the Sheehan Disability Questionnaire

    Through study completion, an average of 1 year

  • +3 more secondary outcomes

Study Arms (2)

Floatation-REST

EXPERIMENTAL

Participants will float supine in a pool of water saturated with epsom salt, in a light and sound attenuated chamber, for up to 60 minutes, on 8 separate occasions. Ratings of the experience will be collected before and after each float.

Behavioral: Floatation-REST plus usual care

Usual care

OTHER

Participants will be assessed along the same time periods, i.e., before and after a 60 minute window, on 8 separate occasions. Ratings of the experience will be collected before and after each time period.

Behavioral: Usual care

Interventions

Individuals will receive Floatation-REST plus usual care. Floating creates an environment with minimal visual, auditory, tactile, proprioceptive, and thermal input to the brain. The float rooms are lightproof and soundproof. A high concentration Epsom salt water solution allows individuals to effortlessly float on their back while remaining completely still, reducing both proprioceptive and tactile input to the brain. The temperature of the water is calibrated to the temperature of the skin (\~94° F) and the temperature of the air is calibrated to the temperature of the water, making it difficult to discern the boundary between air and water, thus reducing thermal input to the brain while minimizing the need for thermoregulation of the skin.

Floatation-REST
Usual careBEHAVIORAL

Individuals will receive usual care on the inpatient unit of the Laureate Eating Disorders Program.

Usual care

Eligibility Criteria

Age13 Years - 64 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Primary clinical diagnosis of anorexia nervosa
  • Receiving inpatient treatment for eating disorder
  • Body mass index greater than or equal to 16
  • No new medication prescription in the week prior to study randomization
  • Independently ambulatory
  • No current evidence of orthostatic hypotension
  • Ability to lay flat comfortably
  • Possession of a smartphone with data plan
  • English proficiency

You may not qualify if:

  • Active suicidal ideation
  • Active cutting or skin lacerating behaviors
  • Orthostatic hypotension (defined as a drop of ≥ 20 mm Hg in systolic BP or a drop of ≥ 10 mm Hg in diastolic BP when measured shortly after transitioning from lying down to standing)
  • Comorbid schizophrenia spectrum or other psychotic disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laureate Institute for Brain Research

Tulsa, Oklahoma, 74136, United States

Location

Related Publications (1)

  • Choquette EM, Flux MC, Moseman SE, Chappelle S, Naegele J, Upshaw V, Morton A, Paulus MP, Feinstein JS, Khalsa SS. The impact of floatation therapy on body image and anxiety in anorexia nervosa: a randomised clinical efficacy trial. EClinicalMedicine. 2023 Aug 29;64:102173. doi: 10.1016/j.eclinm.2023.102173. eCollection 2023 Oct.

MeSH Terms

Conditions

Anorexia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Officials

  • Sahib Khalsa, MD, PhD

    Laureate Institute for Brain Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pragmatic randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2018

First Posted

August 1, 2018

Study Start

March 16, 2018

Primary Completion

March 1, 2022

Study Completion

October 1, 2024

Last Updated

October 5, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations